Hydrochlorothiazide Tablet
Product Images NDC 51655-831

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-831-26 (51655 831 26 Rev A 02 23)

51655-831-26 (51655 831 26   Rev A 02 23)
This is a description of Hydrochlorothiazide Tablets, USP with a strength of 25mg, packaged in a container holding 90 tablets. The NDC code for the product is 51655-831-26. The medication is only available with a prescription. Patients should refer to the package insert for dosage information. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F) and in its original container. Northwind Pharmaceuticals is the repackager of the medication. The manufacturer of the medication is Teva Pharmaceuticals USA, and it was produced in Indianapolis, IN 46203. Each tablet contains hydrochlorothiazide, a diuretic that reduces the amount of water in your body. The medication has a GTIN of 00351655831267, and the lot number is 0000000000. The serial number of the medication is 000000000000000, and the expiration date is 00/00/0000.*
FDA Label Image

Hctz Structural Formula (Image 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.